CONSEQUENCES OBSERVED WHEN MEROPENEM IS ADMINISTERED TO PATIENTS WITH COVID-19

Authors

  • Karimov A. Y.
  • Sherova Z. N. Tashkent Pediatric Medical Institute, Department of Family Medicine № 2 Clinical Pharmacology

Keywords:

Meropenem, COVID-19, coronavirus, pneumonia, Cefaperazone & Sulbactam.

Abstract

Indications for the drug Meropenem in severe and extremely severe forms of the disease in patients infected with coronavirus infection and forecasting of the negative and positive consequences observed in it.

Downloads

Published

2024-03-04

Issue

2024: ICDE-Netherland February

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

CONSEQUENCES OBSERVED WHEN MEROPENEM IS ADMINISTERED TO PATIENTS WITH COVID-19. (2024). E Conference Zone, 34-35. https://econferencezone.org/index.php/ecz/article/view/2743